Literature DB >> 3292316

Evolution of abnormal insulin secretory responses during 48-h in vivo hyperglycemia.

J L Leahy1, G C Weir.   

Abstract

Recent in vitro studies have shown that insulin release caused by continuous exposure to high glucose concentration markedly falls within a few hours. We wanted to determine if a similar effect occurs in vivo with chronic intravenous infusions in normal rats. Male CD rats (200-250 g) were infused with 50% glucose at 2 ml/h for 6, 14, 24, or 48 h, whereas controls received 0.45% NaCl, and insulin responses were tested with the in vitro isolated perfused pancreas. Plasma glucose averaged 352 +/- 20 mg/dl after 4 h and 396 +/- 11 mg/dl after 24 h versus 137 +/- 5 mg/dl in controls; plasma insulin at the same times was 8.94 +/- 1.44 and 12.1 +/- 2.62 ng/ml versus 1.69 +/- 0.19 ng/ml in controls. The incremental insulin response caused by an increase in perfusate glucose from 2.8 to 16.7 mM was not significantly reduced after 24 h of glucose infusion; in contrast, paradoxical suppression was seen after 48 h. A second protocol examined glucose potentiation by giving 10 mM arginine at 2.8 and 16.7 mM glucose; a hyperresponse to arginine at the lower glucose level was present after just 14 h of infusion. Therefore, these results do not support the hypothesis that beta-cells lose their sensitivity to glucose within hours of being exposed to higher than normal glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292316     DOI: 10.2337/diab.37.2.217

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  10 in total

1.  Hyperglucagonemia precedes a decline in insulin secretion and causes hyperglycemia in chronically glucose-infused rats.

Authors:  Rachel A Jamison; Romana Stark; Jianying Dong; Shin Yonemitsu; Dongyan Zhang; Gerald I Shulman; Richard G Kibbey
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-08-23       Impact factor: 4.310

2.  Impairment of glucose-induced insulin secretion in human pancreatic islets transplanted to diabetic nude mice.

Authors:  L Jansson; D L Eizirik; D G Pipeleers; L A Borg; C Hellerström; A Andersson
Journal:  J Clin Invest       Date:  1995-08       Impact factor: 14.808

3.  Hyperglycemia-induced B cell toxicity. The fate of pancreatic islets transplanted into diabetic mice is dependent on their genetic background.

Authors:  O Korsgren; L Jansson; S Sandler; A Andersson
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

Review 4.  The β-cell glucose toxicity hypothesis: Attractive but difficult to prove.

Authors:  Gordon C Weir; Peter C Butler; Susan Bonner-Weir
Journal:  Metabolism       Date:  2021-09-01       Impact factor: 8.694

5.  Beta-cell dysfunction in hyperglycaemic rat models: recovery of glucose-induced insulin secretion with lowering of the ambient glucose level.

Authors:  J L Leahy; G C Weir
Journal:  Diabetologia       Date:  1991-09       Impact factor: 10.122

6.  In vivo and in vitro increased pancreatic beta-cell sensitivity to glucose in normal rats submitted to a 48-h hyperglycaemic period.

Authors:  C Thibault; C Guettet; M C Laury; J M N'Guyen; M A Tormo; D Bailbé; B Portha; L Pénicaud; A Ktorza
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

7.  Neurotransmitters partially restore glucose sensitivity of insulin and glucagon secretion from perfused streptozotocin-induced diabetic rat pancreas.

Authors:  K Ito; H Hirose; H Maruyama; S Fukamachi; Y Tashiro; T Saruta
Journal:  Diabetologia       Date:  1995-11       Impact factor: 10.122

8.  Differential expression of the insulin gene transcriptional repressor CCAAT/enhancer-binding protein beta and transactivator islet duodenum homeobox-1 in rat pancreatic beta cells during the development of diabetes mellitus.

Authors:  J Seufert; G C Weir; J F Habener
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus.

Authors:  C Alarcón; J L Leahy; G T Schuppin; C J Rhodes
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

10.  Hyperglycaemia attenuates in vivo reprogramming of pancreatic exocrine cells to beta cells in mice.

Authors:  Claudia Cavelti-Weder; Weida Li; Adrian Zumsteg; Marianne Stemann-Andersen; Yuemei Zhang; Takatsugu Yamada; Max Wang; Jiaqi Lu; Agnes Jermendy; Yong Mong Bee; Susan Bonner-Weir; Gordon C Weir; Qiao Zhou
Journal:  Diabetologia       Date:  2015-12-23       Impact factor: 10.122

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.